Using AI to transform life sciences data analysis
Using AI to transform life sciences data analysis: An early look at CAILIN’s performance COTA has launched the COTA AI Language Insights Network (CAILIN) to expedite data analytics. CAILIN is an oncology trained, on-demand insight generator designed to answer a variety of fundamental questions pertaining to data analytics, including specific cohort size, subgroup breakdowns, […]
COTA and Guardant Health Partner to Advance Precision Oncology Research and Therapy Development with Real-World Clinicogenomic Data and AI Analytics
NEW YORK–(BUSINESS WIRE)–COTA Inc., a leader in real-world data (RWD) and analytics for oncology, announces a new partnership with leading precision oncology company Guardant Health Inc. (Nasdaq: GH) that will allow biopharmaceutical researchers to access the combined resources of COTA’s research-grade electronic health record (EHR) data from academic and community care centers and Guardant’s clinicogenomic […]
COTA and PHI, a subsidiary of Texas Oncology, partner to deliver precision medicine for cancer patients
For over a decade, COTA has been tackling the most complicated cancer data to produce real-world data that can power research that will improve care and expand treatment options for patients. And now, with the integration of AI into our data curation process, we have the potential to do data-assisted clinical research with more speed […]
Research from COTA and leading global cancer center demonstrate how Real-World Data can fill cancer care gaps for older patients
COTA and Memorial Sloan Kettering Cancer Center will present the findings from their research collaboration on Diffuse Large B-Cell Lymphoma (DLBCL) studies in older patients at the upcoming American Society of Hematology Annual Meeting (ASH) next month.
COTA and Panalgo Q&A
COTA Spokesperson: C.K. Wang, Chief Medical Officer Panalgo Spokesperson: Meg Richards, PhD, MPH, Executive Director of Scientific Strategy Abbreviated answers Q: What is the value of real-world data for accurate healthcare analytics – what can be learned from high-quality electronic health record data? Meg: Real-world data (RWD), particularly those derived from high-quality electronic health records […]
Panalgo Partners with COTA, Adding Oncology Data to Its Industry-Leading IHD Platform
Panalgo, a Norstella company dedicated to revolutionizing healthcare data analytics, has announced its partnership with COTA, an organization that brings clarity to cancer care with a precise, patient-first approach based on real-world data (RWD). BOSTON, Sept. 9, 2024 /PRNewswire-PRWeb/ — Panalgo, a Norstella company dedicated to revolutionizing healthcare data analytics, has announced its partnership with COTA, an organization that […]
COTA and Texas Oncology Collaborate to Advance AI-Enabled Precision Medicine
New York — COTA, Inc., in collaboration with Texas Oncology’s Precision Health Informatics, LLC (PHI), announces an innovative collaboration aimed at revolutionizing precision medicine across Texas Oncology’s community cancer centers. Leveraging COTA’s AI-powered curation engine, CAILIN™, this collaboration will transform fragmented healthcare data into actionable insights. Unlocking Insights from Electronic Health Records (EHRs) Electronic health records […]
COTA and Aetion partner to expand access to real-world data for oncology research
This collaboration enables Aetion and COTA to meet the needs of researchers requiring high-quality, clinically rich oncology data, for both liquid and solid tumor types.
